Peripheral Neuropathy Trial, Recruiting NCT07313566 Sponsor: Universitaire Ziekenhuizen KU Leuven Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT07313566
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have had radiating leg or back pain for at least 6 weeks and have been recommended for lumbar (lower back) surgery such as a discectomy, decompression, or spinal fusion, based on established medical guidelines
  • People who are currently employed, whether actively working or on sick leave for less than one year due to their back condition
  • People aged between 18 and 65 years
  • People whose surgery is planned to take place between 5 days and 2 months after the decision to operate (or within 4 months if spinal fusion is planned)
  • People scheduled for spinal fusion surgery that involves only one or two levels of the spine
  • People who are able to read, understand, and sign a consent form independently, without physical or cognitive barriers to doing so

Who may not be able to join:

  • People whose back surgery is needed because of cancer, a spinal fracture, or a spinal infection
  • People who do not have sufficient knowledge of Dutch or French to receive education at the recruiting centre and complete the study questionnaires
  • People who require emergency surgery immediately, leaving no time for pre-surgery preparation
  • People who are undergoing a repeat (revision) spinal fusion surgery
  • People who do not live in Belgium

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +32 16 34 02 72

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
16 March 2026
Est. completion
1 May 2028

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Time to Return To Work (RTW)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov